Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors

摘要

The present invention describes combination treatment comprising a PD-i axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer. 7440200_1 (GHMatters) P93275.AU.1